CTRI/2017/03/008050
Not yet recruiting
Phase 2
An open labelled multicentric prospective clinical study to assess the effectiveness of Kumarabharana Rasa in recurrent upper respiratory tract infections with special reference to chronic tonsillitis in children
Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital0 sites200 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Chronic tonsillitis
- Sponsor
- Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
- Enrollment
- 200
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children of both genders between 5\-10 years of age, who were suffering from repeated attacks of tonsillitis (chronic) in past year. Those participants whose parents are ready to sign the consent form and allow their children to participate in the clinical trial will be included.
Exclusion Criteria
- •Patients with acute tonsillitis, peritonsillar abscess, tonsillar cyst, tonsillolith or with any other systemic disorders. Also the patients who have taken systemic steroids and/or antibiotics in the past four weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
A study to assess the safety and efficacy of fixed dose combination of Montelukast 10 mg plus Acebrophylline SR 200 mg tablet in patients having bronchial asthmaCTRI/2020/02/023237Sun Pharma Laboratories Limited
Completed
Phase 3
To evaluate safety and performance of CREDENCEâ?¢ BtK Sirolimus Eluting BioResorbable Peripheral Scaffold System in subjects with Critical Limb Ischemiafollowing Percutaneous Transluminal Angioplasty of below the knee arteries.Health Condition 1: I739- Peripheral vascular disease, unspecifiedCTRI/2016/11/007473Meril Life Sciences Pvt Ltd30
Completed
Phase 2
Clinical study on JPF-16 Capsules in Sexual Dysfunction in FemalesHealth Condition 1: null- Female Sexual DysfunctionCTRI/2017/06/008791Chatarubhuj Pharmaceutical Co30
Completed
Not Applicable
A clinical trial to test the safety and effectiveness of Neuralzhein in management of memory loss related to age.Health Condition 1: F54- Psychological and behavioral factors associated with disorders or diseases classified elsewhereCTRI/2019/08/020711exxus Laboratories DBA OPUS PHARMA
Recruiting
Phase 1
A clinical study to assess how safe and effective it is for subjects with hepatocellular carcinoma (HCC) to receive radiation therapy with TheraSphere followed by immunotherapy (durvalumab and tremelimumab treatment)Hepatocellular CarcinomaMedDRA version: 21.1Level: LLTClassification code: 10049010Term: Carcinoma hepatocellular Class: 10029104Therapeutic area: Diseases [C] - Digestive System Diseases [C06]CTIS2023-508945-41-00Biocompatibles UK Limited107